Remove Communication Remove HIPAA Remove Webinar
article thumbnail

Recap of HLC’s 2023 Webinars

Healthcare Leadership Council

The Healthcare Leadership Council hosted 10 webinars in 2023 on various healthcare topics prioritized by its members. Shared responsibility across healthcare sectors enables enhanced communication, actionable data, and care coordination. They also addressed barriers faced and recommendations for a better future.

article thumbnail

How to Implement HIPAA-Compliant Texting & Boost Patient Engagement

DrChrono

Communication norms are constantly shifting, and patient communications are no exception. In the health tech space, that’s led to the emergence of a variety of practice management software features ranging from telemedicine platforms to patient communication services.

HIPAA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitizing Compliance Management in Healthcare

Relias

For instance, according to The HIPAA Journal , the maximum penalty for HIPAA rule violations in 2024 is $2,067,813 per violation per calendar year. Introducing the Relias Compliance Pro Suite Discover the Relias Compliance Pro Suite at your convenience with our on-demand webinar. Watch the Webinar 4.

HIPAA 52
article thumbnail

Top 10 Questions to Ask When Selecting an EHR

Valant

Does the vendor offer items such as live webinars, self-paced lessons, and a robust knowledge base? Among other items, your communications with patients must be HIPAA-compliant , which is one reason why a secure patient portal is key. What kind of training and support does the EHR vendor offer during implementation and beyond?

Billing 40
article thumbnail

Transforming Field Reimbursement with AI: Introducing ReimbursementAI

ACMA Blog

Therefore, FRMs must be highly-knowledgeable communicators who realize the importance of urgency in patient access. In a highly-informative webinar with ACMA, Shandro highlighted key takeaways from his experiences with risk management in biotechnology companies (Soliman & Shandro, 2024).